Search

for
Search:

Research

5 / 1000+ results

research Group Treatment for Trichotillomania: Behavior Therapy Versus Supportive Therapy

69 citations , August 2006 in “Behavior Therapy”

This study found that group behavior therapy for trichotillomania led to greater short-term symptom improvement compared to supportive therapy, but did not achieve clinically significant changes or prevent relapse over six months.

Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus

research Chinese SLE Treatment and Research group (CSTAR) registry 2009–2019: Major clinical characteristics of Chinese patients with systemic lupus erythematosus

15 citations , March 2021 in “Rheumatology and Immunology Research”

The CSTAR registry, the largest in China for SLE, reports more than 25,000 patients registered since 2009, detailing demographics, clinical characteristics, and providing data for future studies.

Chinese SLE Treatment and Research Group Registry XIII: Prevalence and Risk Factors for Chronic Scarring Alopecia in Patients with Systemic Lupus Erythematosus

research Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus

1 citations , January 2021 in “Arthritis Research & Therapy”

The study reported a 7.80% prevalence of scarring alopecia in Chinese SLE patients and identified several risk factors, including mucocutaneous lesions and high disease activity, while renal and cardio-respiratory involvements were negatively associated with it.

research Chinese SLE Treatment and Research Group (CSTAR) Registry: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus

November 2020 in “Research Square (Research Square)”

This study found that 7.80% of Chinese patients with systemic lupus erythematosus experienced scarring alopecia, with certain disease characteristics and treatments influencing its prevalence.

research Chinese SLE Treatment and Research Group (CSTAR) Registry: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus

August 2020 in “Research Square (Research Square)”

This study reported that 7.80% of systemic lupus erythematosus patients experienced scarring alopecia, with mucocutaneous lesions and certain autoantibodies identified as risk factors, and some organ involvements and immunosuppressants as protective factors.

View more "treatment group" in research →

Community Join

5 / 1000+ results

community New groundbreaking hair loss treatment -- Exosomes

4 upvotes 6 years ago

Exosomes are discussed as a new hair loss treatment, but skepticism is expressed about their effectiveness. Other treatments mentioned include Minoxidil, finasteride, and RU58841.

community Still losing ground slowly with Dutasteride + Minoxidil + Dermarolling + Nizoral over the course of 1.25 years of total treatment

in Update 13 upvotes 1 year ago

The user is experiencing slow hair loss despite using Dutasteride, Minoxidil, Dermarolling, and Nizoral for 1.25 years and is considering further tests and treatments. They are also supplementing with vitamin D and iron and using a prescribed steroid cream.

community 19 months in, losing ground somehow

in Treatment 2 upvotes 7 months ago

The user has been using finasteride 1mg and minoxidil 5% spray for 19 months but continues to experience hair shedding and has not seen improvement with ketoconazole or tretinoin. They are considering a hair transplant in the future while maintaining current treatments.

community Lost ground on Dut, Min, RU, etc (5 yrs… 2021->2026)

16 upvotes 5 months ago

The user has been using a combination of treatments including Dutasteride, Minoxidil, RU58841, ketoconazole shampoo, microneedling, and low-level laser therapy to address hair loss but continues to experience shedding and density loss. Despite high testosterone and iron levels, the user is frustrated with the lack of improvement and is considering adjusting treatment or exploring other options like a hair transplant.

community Losing ground on 1.5 fin only, am i imagining it or is this lost ground?

7 upvotes 2 weeks ago

The user is experiencing hair thinning and is considering adding Minoxidil to their current finasteride treatment. Suggestions include using Minoxidil, possibly switching to Dutasteride, and considering microneedling and RU58841.

View more "treatment group" in community →

Learn

10 / 801 results

learn Scalp Micropigmentation

Is there an age limit for scalp micropigmentation? Most providers say there is no upper age limit for scalp micropigmentation, and about half set a minimum of 18, matching tattoo law in the UK and most US states. A minority advertise lower minimums with parental consent, which may not be legal where you live.

learn Redensyl

Redensyl, Capixyl, Procapil, Anagain, and Baicapil: the wonder group of hair loss products. Redensyl, Capixyl, Procapil, Anagain, and Baicapil are promising alternatives for hair loss treatment.

learn Botox

What’s the science behind Botox injections for androgenetic alopecia? Small published studies and a 2025 meta-analysis report hair-count gains from scalp botulinum toxin injections, but nearly all of them lack control groups, and reviewers of the same literature call the evidence low-quality; the treatment is off-label and not approved for hair loss anywhere.

learn Setipiprant

What side effects or limitations have been reported with Setipiprant use in hair loss research? In the one published hair-loss trial (DuBois 2021, 169 men, 24 weeks), setipiprant produced no significant hair regrowth over placebo. Treatment-related side effects — mostly mild headaches, stomach upset and fatigue — were reported in about a quarter of the setipiprant group versus just over twelve percent on placebo, and no serious events were attributed to the drug. It is an unapproved, experimental compound with no long-term safety data.